13F-HR: GILEAD SCIENCES, INC.
Ticker: GILD · Form: 13F-HR · Filed: 2025-02-13T00:00:00.000Z
Sentiment: neutral
Topics: 13f-hr
AI Summary
13F-HR filing by GILEAD SCIENCES, INC..
Risk Assessment
Risk Level: low
From the Filing
0001123292-25-000079.txt : 20250213 0001123292-25-000079.hdr.sgml : 20250213 20250213161447 ACCESSION NUMBER: 0001123292-25-000079 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250213 DATE AS OF CHANGE: 20250213 EFFECTIVENESS DATE: 20250213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-25078 FILM NUMBER: 25620437 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0000882095 XXXXXXXX 12-31-2024 12-31-2024 false GILEAD SCIENCES, INC. 333 LAKESIDE DR FOSTER CITY CA 94404 13F HOLDINGS REPORT 028-25078 N Andrew D. Dickinson Executive Vice President and Chief Financial Officer 650-574-3000 /s/ Andrew D. Dickinson FOSTER CITY CA 02-13-2025 1 16 1551148266 1 0002055207 Gilead Therapeutics A1 Unlimited Co INFORMATION TABLE 2 informationtable.xml AGENUS INC COM NEW 00847G804 634757 231663 SH SOLE 231663 0 0 ALLOGENE THERAPEUTICS INC COM 019770106 2463748 1156689 SH SOLE 1156689 0 0 ALLOVIR INC COM 019818103 6986820 16635286 SH SOLE 16635286 0 0 ARCELLX INC COMMON STOCK 03940C100 515418382 6720803 SH SOLE 6720803 0 0 ARCUS BIOSCIENCES INC COM 03969F109 447610136 30061124 SH SOLE 30061124 0 0 ASSEMBLY BIOSCIENCES INC COM NEW 045396207 34865452 2209471 SH SOLE 2209471 0 0 GALAPAGOS NV SPON ADR 36315X101 461727194 16707477 SH DFND 1 16707477 0 0 HOOKIPA PHARMA INC COM NEW 43906K209 3770649 1875945 SH SOLE 1875945 0 0 KRONOS BIO INC COM 50107A104 179139 188567 SH SOLE 188567 0 0 TANGO THERAPEUTICS INC COM 87583X109 15000229 4854443 SH SOLE 4854443 0 0 BARINTHUS BIOTHERAPEUTICS PL ADS 91864C107 749384 620351 SH SOLE 620351 0 0 KYVERNA THERAPEUTICS INC COM 501976104 15431685 4126119 SH SOLE 4126119 0 0 IKENA ONCOLOGY INC COM 45175G108 3293674 2008338 SH SOLE 2008338 0 0 XILIO THERAPEUTICS INC COM 98422T100 8695706 9105451 SH SOLE 9105451 0 0 LEAP THERAPEUTICS INC COM NEW 52187K200 15292551 5319148 SH SOLE 5319148 0 0 MERUS N V COM N5749R100 19028760 452527 SH SOLE 452527 0 0